The prenylflavonoid, xanthohumol (1) is the major constituent of the female inflorescences (hops) of Humulus lupulus L. (Cannabinaceae).
1) The use of hops in the brewing industry makes 1 an important constituent of beer. 1 and other minor prenylchalcones are converted into the corresponding isomeric prenylflavanones during the brewing process.
2) Xanthohumol is also a component of some dietary supplements and acts as an antiproliferative agent in ovarian, colon and breast cancer cells. 3) In addition, it may have cancer-chemopreventive properties 4, 5) and has been patented as a drug for osteoporosis treatment. 6) In vitro studies of 1 with rat and human liver microsomes have yielded several oxygenated derivatives and glucuronides. 7, 8) The biological activities of those metabolites are yet to be determined.
The aim of the microbial transformation studies of 1 was to generate mammalian metabolites which may contribute to the understanding of its biological activities and to be used as analytical standards for the detection of these metabolites in biological fluids. [9] [10] [11] Previous work on the microbial transformation of 1 with cultures of the fungus, Pichia membranifaciens (ATCC 2254), resulted in the formation of (E)-
]-2Ј,4-dihydroxy-6Ј-methoxychalcone (2) was identical to that obtained using rat liver microsomes. 7) We now report on the microbial transformation of 1 with Cunninghamella echinulata NRRL 3655 and the screening of these products for cytotoxicity towards mammalian cell lines and for their potential antimicrobial and antimalarial properties.
Results and Discussion
Twenty microorganisms were used to identify organisms capable of metabolizing xanthohumol (1) . The standard twostage procedure 9 ) was adopted to screen the organisms. TLC indicated that several organisms were capable of transforming 1. In the previous investigations with the fungus, Pichia membranifaciens (ATCC 2254) three metabolites, (2), (3), and (4) (Fig. 1) were isolated and characterized. 12) We selected Cunninghamella echinulata NRRL 3655 for scale-up studies as it gave different metabolites than those obtained with the former organism. This transformation afforded the new ( Table  1) . Three chalcone related products were also isolated. However, these were formed in concentrations (less than 1 mg, each) that did not permit their structure elucidation.
High-resolution electrospray ionization mass spectrometric data (HR-ESI-MS) of 5 and 6 suggested a molecular formula of C 21 H 22 O 6 for each indicating that they were monooxygenated derivatives of 1. Both compounds recorded a maximum absorption at 290 nm and an inflection at 320 nm suggesting a flavanone skeleton. 13) In the 1 H-NMR spectrum of 5, the B-ring protons, H-2Ј/H-6Ј and H-3Ј/H-5Ј appeared as doublets at d 7.29 (Jϭ8.5 Hz) and d 6.78 (Jϭ8.5 Hz). The major differences in the NMR spectrum of 5 as compared to 1, were the disappearance of signals due to the olefinic H-a, H-b protons and the appearance of signals at d 5.33 (H-2, dd, Jϭ3.0, 12.0 Hz) and double-doublets at d 2.91 and d 2.59, typical of the C-ring protons of flavanones. These data, together with observation of a singlet at d 1.63 due to a single allylic methyl group and a two-proton singlet at d 3.96 emanating from a hydroxymethylene functionality, suggested oxygenation at one of the methyl groups of the isoprenyl moiety. The long-range 1 H-and 13 C-NMR correlations were in complete agreement with structure 5. The nuclear Overhauser effect spectroscopy (NOESY) spectrum of 5 showed spatial proximities between the methine proton (d 5.15, H-2Љ) and the methyl protons (d 1.63, H-2Љ). A similar dipolar interaction was observed between the methylene protons (d 3.96, H-4Љ) and the benzylic methylene protons (d 3.17, H-1Љ) confirming the Z-configuration of the double bond. In the CD spectrum of 5, the high amplitude positive Cotton effect in the 290-300 nm region and the negative Cotton effect in the 330-340 nm region allowed the assignment of (R)-configuration at the C-2 stereocenter 14) indicating the stereospecificity of the C-ring cyclization process. This contrasts with the formation of the 2S-flavanone 3 using P. membrani- The 1 H and 13 C data collated in Table 1 for flavanones 5 and 6 were fully corroborated by appropriate 2D NMR experiments, e.g. correlation spectroscopy (COSY), NOESY, 1 H-detected heteronuclear multiple quantum coherence (HMQC) and heteronuclear multiple bond connectivity (HMBC).
Identification and Biological Activity of Microbial Metabolites of Xanthohumol
Xanthohumol (1) and its products of microbial transformation 2-6 (see ref. 12 for 2-4) together with the three undefined polar compounds, showed no cytotoxic activity at 2.78, 8.33 and 25 mg/ml (data not shown) against human cancer cell lines, SK-MEL (malignant, melanoma), KB (epidermal carcinoma, oral), BT-549 (ductal carcinoma, breast) and SK-OV-3 (ovary carcinoma) as well as non-cancerous Vero cells (monkey kidney fibroblasts). Such absence of cytotoxicity towards mammalian cells may contribute towards the safety of xanthohumol containing products for human consumption. No cell proliferation activity was detected. None of the metabolites showed antibacterial or antifungal activity at 50, 10, and 2 mg/ml (data not shown). However, antimalarial activity was exhibited by compounds 1-3 and 6 against D6 (chloroquine sensitive) and W2 (chloroquine resistant) strains of the malaria parasite, Plasmodium falciparium (Table 2 ). Both 1 and 2 were active against D6 and W2 strains with IC 50 values of 3.3 and 1.0 mg/ml and 4.1 and 1.8 mg/ml, respectively. Flavanone 3 was active against D6 strain (IC 50 , 2 mg/ml) and 6 was active against W2 strain (IC 50 , 3.2 mg/ml). The selectivity index of antimalarial activity of these compounds ranged from Ͼ6.1 for compound 2 to Ͼ25.0 for compound 1. Organisms and Metabolism The twenty microorganisms used for screening were obtained from the National Center for Natural Products Research, University of Mississippi. Fermentation experiments were carried out in medium a, consisting of dextrose, 20 g; NaCl, 5 g; K 2 HPO 4 , 5 g; bacto-peptone (Difco Labs), 5 g and yeast extract (Difco Labs, Detroit, MI, U.S.A.), 5 g per liter of distilled water. Initial fermentations were conducted in 125 ml Erlenmeyer flasks containing 25 ml medium a. A two-stage fermentation procedure was adopted in all experiments. 15 ) Xanthohumol 1 was added in dimethylformamide (0.5 mg/ml) to 24 h old stage II cultures. They were incubated at room temperature on a rotary shaker (New Brunswick Model G10-21) at 100 rpm for a period of 14 d. Sampling and TLC monitoring were carried out at 7-d intervals. Precoated Si gel 60 F 254 plates (E. Merck) were used with CHCl 3 -MeOH (9 : 1) as the solvent system. UV light (254 nm) and p-anisaldehyde spray reagent were used to visualize the spots. Scale-up fermentations were performed under the same conditions with six 2 l flasks, containing 500 ml of medium a and 150 mg of substrate, each. Extractions of the culture filtrates and residues were carried out with EtOAc. The solvent was evaporated in vacuo at 40°C to obtain the residues. The isolation of metabolites was by column (Si gel 230-400 mesh: E. Merck) and preparative layer (Si gel 60 F 254 ) chromatography. Culture and substrate controls were run simultaneously with the above experiments. 16) Microbial Transformation of Xanthohumol (1) by C. echinulata The filtrate of the combined fermentation broth was exhaustively extracted with EtOAc. On evaporation of the solvent a yellowish solid was obtained (500 mg). It was column chromatographed (Si gel 230-400 mesh: E. Merck, 30 g, column diameter: 20 mm) using CHCl 3 gradually enriched with MeOH.
The combined fractions were purified by preparative layer chromatography (CHCl 3 -MeOH, 9 : 1). (2S)-8-[5Љ-Hydroxy-methyl-(2Љ-Z)-butenyl]-4Ј,7-dihydroxy-5-methoxyflavanone (5) In vitro antimalarial activity was tested against two strains (D6, chloroquine sensitive and W2, chloroquine resistant) of the malarial parasite, according to a modification of the method described by Makler et al. 20) The activity of plasmodial LDH is determined as an indicator of the number of parasites remaining in infected RBCs, following incubation with samples. IC 50 , the concentration that causes 50 % growth inhibition of the parasite, was calculated from the dose curves generated by plotting concentrations against percent growth inhibition. 
